P3 Health Partners Inc（PIII）财务数据PIIIP3 Health Partners Inc

Evaluating the bottom line, P3 Health Partners Inc maintains a gross margin of 22.26%. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at 10.67%, while the net margin is 4.05%. These profitability ratios, combined with a Return on Equity (ROE) of -87.57%, provide a clear picture of how effectively PIII converts its operational activities into shareholder value.

In the context of the broader market, PIII competes directly with industry leaders such as KPLT and KLTO. With a market capitalization of $29.11M, it holds a significant position in the sector. When comparing efficiency, PIII's gross margin of 22.26% stands against KPLT's 26.79% and KLTO's N/A. Such benchmarking helps identify whether P3 Health Partners Inc is trading at a premium or discount relative to its financial performance.

P3 Health Partners has shown significant revenue growth, with Q2 2026 revenue at $386.4 million, a 9% increase year-over-year, and a notable recovery in net income, achieving $15.7 million compared to a loss last year.